Day: November 4, 2024

BOCA RATON, FL, Nov. 04, 2024 (GLOBE NEWSWIRE) — Janover Inc. (Nasdaq: JNVR) (“Janover” or the “Company”), an AI-enabled platform connecting the commercial real estate industry, is pleased to announce a licensing agreement with one of the nation’s top 20 publicly traded commercial real estate professional services firms. Through this partnership, Janover’s AI tools will be deployed to enhance client engagement and streamline communication, setting a new standard for service and efficiency in commercial real estate. This agreement marks a milestone in Janover’s transition to subscription revenue including licensing its highly customized conversational artificial intelligence. “This deployment with a major industry leader underscores the real-world demand for our AI as the battle to deliver better services and data more efficiently...

VANCOUVER, British Columbia, Nov. 04, 2024 (GLOBE NEWSWIRE) — Vital Battery Metals Inc. (“Vital” or the “Company”) (CSE: VBAM | OTC: VBAMF | FRA: C0O), is pleased to announce the completion of its fall 2024 drilling campaign at the Company’s Sting Copper Project (“Project” or “Sting”), located in western Newfoundland, Canada. Over the course of the program, a total of 912 meters have been drilled in 5 drill holes (Figs. 1-2, Table 1), that all successfully intersected zones with chalcopyrite and pyrite mineralization* ranging in form from disseminations and stringers to semi-massive zones associated with veining or regional lithological contacts and faulting.Figure 1: Sting Copper Project Location MapFigure 2: Sting Copper Project drilling overview. Soil samples shown include additional anomalous samples collected during the...

HAYWARD, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference (“ddRNAi”) platform, today announces CEO Jerel A. Banks, M.D., Ph.D. will be participating in the Guggenheim Securities Healthcare Conference, taking place in Boston from November 11-13, 2024. Date: November 11, 2024Time: 2:30 PMFormat: Fireside Chat & 1×1 Meetings The Benitec presentation will also be available via live webcast here. Please contact your Guggenheim representative to schedule a 1×1 meeting with Benitec management. About Benitec Biopharma Inc.Benitec Biopharma Inc. (“Benitec” or the “Company”) is a clinical-stage...

DENVER, Nov. 04, 2024 (GLOBE NEWSWIRE) — InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Michael Scarbrough as its new President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services, effective November 4th. Mr. Scarbrough joins InnovAge’s executive leadership team as Christine Bent steps down from the role of COO to explore new career opportunities. Scarbrough will also assume the role of President as the Company separates the positions of President and CEO to better enable execution of strategic priorities. The InnovAge team extends its gratitude to Ms. Bent for her exceptional service and numerous contributions, which...

TORONTO, Nov. 04, 2024 (GLOBE NEWSWIRE) — CHAR Technologies (“CHAR Tech” or the “Company”), a leader in sustainable energy solutions, is pleased to announce the transition of the Altech Environmental Consulting team and assets to Cambium Inc., a well-established provider of Environmental Consulting & Geotechnical Engineering services across Ontario. This transition aligns with CHAR’s ongoing strategy to focus on its renewable energy initiatives, allowing Altech’s team, projects, clients, and intellectual property to continue seamlessly under Cambium’s respected brand. This alignment supports CHAR Tech’s 2025 objectives to focus resources to the delivery of their build, own, and operate commercial woody biomass to renewable energy projects. Through this transition, Cambium Inc. will broaden its environmental consulting offerings,...

Management to Announce Earnings Results and hold a call at 8:30 am ET AUSTIN, Texas, Nov. 04, 2024 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that the Company will report its financial results for the three and nine months ended September 30, 2024, on Thursday, November 14, 2024. Management will also host a conference call at 8:30 am ET to discuss financial results and provide a corporate update. Details of the call are as follows:Conference Call & Webcast Details:Date: Thursday, November 14, 2024Time: 8:30 am ETToll Free: 877-545-0320International: 973-528-0002Access Code: 436613Webcast: Registration LinkA replay of the webcast...

Bethesda, MD, Nov. 04, 2024 (GLOBE NEWSWIRE) — HWH International Inc. (Nasdaq: HWH) is pleased to announce the launch of its proprietary business-to-consumer marketplace, Hapi Marketplace, which aims to offer a diversity of high-quality yet price competitive products. Hapi Marketplace features an extensive selection of over forty-seven product categories including wellness, elderly care, auto accessories and more. A special range of products are sourced by our team, allowing our customers to shop with confidence among a wide range of options. What sets Hapi Marketplace apart is its commitment to offering innovative products and customer care. The platform seeks to allow users to enjoy a smoother, more efficient shopping journey. This serves as a valuable offering for our members, enhancing our lifestyle membership. “Our mission...

Data from the AscenD-LB Phase 2a trial in DLB confirm recent scientific literature indicating that plasma glial fibrillary acid protein (GFAP) is a robust measure of neurodegenerative disease activity in DLB Neflamapimod treatment previously led to significant reduction in plasma GFAP levels (p=0.015 versus placebo) and these reductions were associated with an improvement in clinical outcomes The RewinD-LB Phase 2b clinical study successfully enrolled a DLB patient population that is optimized to show the treatment effect of neflamapimod when topline data are reported in December BOSTON, Nov. 04, 2024 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for age-related neurologic disorders, today announced key takeaways from two oral presentations characterizing the potential...

The customer, operating a multi-million cross-region network, is set to gain best-in-class data-driven capabilities, positioning itself to achieve sustained market leadership, by subscribing to both NetNut’s IPPN and Website Unblocker offerings TEL AVIV, Israel, Nov. 04, 2024 (GLOBE NEWSWIRE) — Alarum Technologies Ltd. (Nasdaq, TASE: ALAR) (“Alarum” or the “Company”), a global provider of internet access and web data collection solutions, today announced the expansion of its recently established relationship with a leading global Fortune 200 company, which has subscribed to the newly rolled-out Website Unblocker from NetNut, in addition to Internet Protocol Proxy Network (IPPN). The customer, operating a multi-million cross-region network, and a multi-billion US Dollar business, will enhance automation and customer spending while...